Program Directors

William P. Timmie Professor of Psychiatry and Behavioral Sciences
Vice Chair of Research, Department of Psychiatry and Behavioral Sciences
Director, Psychiatry Residency Research Track

Dr. Andrew H. Miller is William P. Timmie Professor and Vice Chair for Research in the Department of Psychiatry and Behavioral Sciences at the Emory University School of Medicine. He is also the Director of the Psychiatry Residency Research Track. He is an internationally recognized expert in interactions between the brain and immune system as they relate to depression. His work has demonstrated that during immune activation, inflammatory cytokines can access the brain and interact with the metabolism of dopamine and glutamate, while altering neurocircuits relevant to motivation and reward as well as anxiety and alarm. Additionally, Dr. Miller and his group conducted the first clinical trial examining the efficacy of an immunotherapy (cytokine antagonist) for the treatment of depression. He has produced over 250 scholarly publications, won numerous research, teaching and mentoring awards, is an ISI highly cited researcher and is a Board-Certified Psychiatrist.

Associate Professor, Department of Psychiatry and Behavioral Sciences
Director, Psychiatry Residency Research Track

Dr. David R. Goldsmith is an Associate Professor in the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine and Program Director for the Psychiatry Residency Research Track. He serves as Co-Director of the Clinical and Research Program for Psychosis, Medical Director of the Emory Behavioral Immunology Program and Emory Co-Director of the Georgia Clinical and Translational Science Alliance TL1 Training Program. Dr. Goldsmith’s research program investigates the impact of inflammatory markers on brain reward circuitry, motivational deficits and negative symptoms in patients with schizophrenia. He is currently funded by an R01 from the National Institute of Mental Health to use the TNF-antagonist infliximab in an experimental medicine study testing its effects on brain circuitry and behavior, which builds on data collected during his K23 Career Development Award. Clinically, Dr. Goldsmith is the Director of the PSTAR (Persistent Symptoms: Treatment, Assessment and Recovery) Clinic where he treats patients with persistent symptoms of psychosis. Dr. Goldsmith serves as an Associate Editor of Schizophrenia Research and on the Editorial Board of Brain, Behavior and Immunity. He is also an Associate Member of the American College of Neuropsychopharmacology. He has been recognized a number of times for his research and teaching including two Dean’s Teaching Awards from the Emory University School of Medicine in addition to awards from the Schizophrenia International Research Society and the Society of Biological Psychiatry.

Professor of Psychology and Psychiatry and Behavioral Sciences
Co-Director, Psychiatry Residency Research Track

Dr. Michael T. Treadway is a Professor in the Departments of Psychology and Psychiatry and Behavioral Sciences. He is also the Co-Director of the Psychiatry Residency Research Track. He is a clinical psychologist and neuroscientist focused on understanding the molecular and circuit-level mechanisms of psychiatric symptoms related to mood, anxiety and decision-making. He received his PhD in clinical psychology from Vanderbilt University in 2012 and completed his clinical internship and post-doc at McLean Hospital/Harvard Medical School. As Director of the Translational Research in Affective Disorders Laboratory (TReADLab) in the Department of Psychology at Emory University, Dr. Treadway’s research employs a variety of methods, including multimodal neuroimaging techniques (fMRI, MRS and PET), behavioral paradigms, computational modeling and clinical/personality assessment. A particular interest has been the assessment of reward motivation in psychiatric populations, for which Dr. Treadway has developed several widely used behavioral measures.

Assistant Professor, Department of Psychiatry and Behavioral Sciences
Associate Director, Psychiatry Residency Research Track

Dr. Jessica A. Cooper is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine and is the Associate Director for the Psychiatry Residency Research Track. She is also the Assistant Director of the Translational Research in Affective Disorders Laboratory in the Department of Psychology at Emory University. Dr. Cooper is currently funded by a K01 career development award from the National Institute of Mental Health to investigate elevated inflammation and altered glutamatergic functioning as transdiagnostic mediators of stress-induced anhedonia. She primarily studies the neurobiology of motivation, decision making and response to reward using fMRI and computational modeling.